Discover how Vysnova, in partnership with NAMRU-2, is pioneering advancements in disease surveillance and control through the SABER II program in Southeast Asia. Learn how their innovative approaches are tackling threats from Malaria to COVID-19 and shaping the future of public health.
Discover how a collaborative effort between Vysnova, the London School of Hygiene and Tropical Medicine (LSHTM), and the Lao National Animal Health Laboratory is tackling the potential pandemic threat posed by emerging strains of Influenza A Viruses (IAV) in Southeast Asia. This case study explores the challenges faced by low- and middle-income countries (LMICs) in the region and highlights the importance of proactive surveillance and research in resource-constrained environments. Learn about the findings from extensive interviews, surveys, and lab work, which aim to characterize the risks associated with novel and emerging influenza strains. Find out how these efforts contribute to global public health by enhancing our understanding of IAV dynamics and developing effective surveillance strategies to mitigate future risks. The article concludes with recommendations for continued strategic collaborations, enhanced surveillance measures, and further research to refine pandemic prevention strategies based on these learnings.
Marketing automation software is playing an unexpected role in the fight against COVID-19...Before the start of the COVID-19 pandemic, Derek Kuprianov worked as a digital marketer for a media channel, using marketing automation software to improve the company’s approach to customer engagement and retention. In March 2021, he saw an opportunity he couldn’t pass up—a chance to work with Vysnova Partners, which would eventually be the central coordinating body of a complex study designed to produce real-time data about the virus and its spread across the southeastern United States.
Background Wearing facemasks amid the COVID-19 pandemic has proven effective in preventing transmission and subsequently saving lives. However, the US population has showcased a varying degree of willingness to wear facemasks in the interest…
Vysnova supports a government-funded COVID-19 research study and to achieve project objectives, Vysnova partnered with six Universities and Health Systems across the United States. The study design included a cohort of approximately 43,000 participants with Vysnova, Atrium Health Wake Forest Baptist, and Oracle to conduct a major study of COVID-19 and its impact on communities...
Vysnova is proud to be a co-collaborator of a publication in the Journal of Community Health, a peer-reviewed publication that offers original articles on the practice, teaching, and research of community health. Survey of Adherence with COVID‐19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID‐19 Community Research Partnership
______________________________________________________ About LEPP – Transferring Physical Capital to Aid U.S. Emergency and Development Programs Overseas Vysnova partners with USAID’s Limited Excess Property Program (LEPP); an innovative…
What is Plasmodium falciparum? Plasmodium falciparum is a unicellular protozoan parasite of humans and the deadliest species of Plasmodium that causes malaria in humans. The parasite is transmitted through the bite of a female Anopheles…
Safety, Tolerability and Pharmacokinetics of Tafenoquine After Weekly and Escalating Monthly Doses of Tafenoquine in Healthy Vietnamese Volunteers (TQ Study) Project Purpose:  Primary Objective: In a dose-escalating study in the same healthy…
Currently, there are major gaps in scientific knowledge concerning COVID-19 risk factors, transmission dynamics, seasonal and geographic patterns, correlations between immune markers and reinfection, and long-term immunologic, physiologic, and clinical sequelae of infection.